Screener
CytomX Therapeutics CTMX Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 25,199 | 19,944 | 55,130 | 48,239 |
| Income (loss) from operations | (23,781) | (1,286) | (43,453) | 21,336 |
| Interest income | 3,157 | 1,178 | 4,647 | 2,133 |
| Other income | 18 | 17 | 11 | 28 |
| Income (loss) before income taxes | (20,606) | (91) | (38,795) | 23,497 |
| Provision for income taxes | 60 | 63 | 119 | 126 |
| Net income (loss) attributable to common stockholders | (20,666) | (154) | (38,914) | 23,371 |
| Other comprehensive income (loss): |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is CytomX Therapeutics's other income (expense)?
- CytomX Therapeutics (CTMX) reported other income (expense) of $18K in Q2 2026.
- How has CytomX Therapeutics's other income (expense) changed year-over-year?
- CytomX Therapeutics's other income (expense) increased by 5.9% year-over-year, from $17K to $18K.
- What is the long-term trend for CytomX Therapeutics's other income (expense)?
- Over 2 years (2021 to 2024), CytomX Therapeutics's other income (expense) has grown at a -31.5% compound annual growth rate (CAGR), from -$83K to -$39K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about CytomX Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude